CJC-1295 DAC 5mg
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to increase plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). The addition of a Drug Affinity Complex (DAC) extends the plasma half-life of CJC-1295, making it more effective over a longer period.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to increase plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). The addition of a Drug Affinity Complex (DAC) extends the plasma half-life of CJC-1295, making it more effective over a longer period.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to increase plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). The addition of a Drug Affinity Complex (DAC) extends the plasma half-life of CJC-1295, making it more effective over a longer period.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
What is CJC-1295?
CJC-1295 is a modified version of GHRH, specifically consisting of the first 29 amino acids of GHRH. This analogue, technically a maleimido derivative of hGRF(1-29), was developed to create a more soluble and easily produced growth hormone secretagogue while retaining the physiological actions of GHRH. The goal was to develop a peptide that could be manufactured in large quantities and maintain the effectiveness of GHRH.
CJC-1295 No DAC vs. CJC-1295 DAC
CJC-1295 can exist in two forms: with DAC and without DAC.
CJC-1295 No DAC: This version is chemically similar to other GHRH analogues, such as Sermorelin, and lacks the added Drug Affinity Complex.
CJC-1295 DAC: This version includes an added chemical compound called the Drug Affinity Complex (DAC), linked via a lysine linker. The DAC protects the peptide as it circulates in the bloodstream by binding to the common blood protein albumin. This significantly extends the half-life of CJC-1295, making it last much longer in the body compared to similar molecules like GRF (1-29).
CJC-1295 DAC Peptide Structure
Source: Oxford Academic
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-DAC
Molecular Formula: C152H252N44O42
Molecular Weight: 3647.954 g/mol
PubChem CID: 91976842
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
